- Home
- /
- News
- /
- Target Identification/ Validation
- /
- April 2010
Target Identification/ Validation News for April 2010
Evotec AG announced recently that it will receive funding of up to €1.5 million from the German Federal Ministry of Education and Research to advance its H3 receptor antagonist programme into the clinic.
29 April, 2010
Scientists have made a major breakthrough in identifying new treatments for human African trypanosomiasis, a fatal disease that infects tens of thousands of Africans each year.
01 April, 2010